Oyster Point Pharma, Inc.

Ownership Transactions Reported by 15 Insiders

Industry
Biological Products, (No Diagnostic Substances)
Location
202 Carnegie Center, Suite 106, Princeton, New Jersey

There are no Buy or Sell transactions made by insiders since 7/8/2023

Oyster Point Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
William J. Link Phd Director $5.47 M Jan 5, 2022
John Snisarenko Chief Commercial Officer $340 K Jan 9, 2022
Donald J. Santel Director Jan 3, 2023
Versant Venture Capital VI, L.P. 10%+ Owner Jan 3, 2023
Clare Ozawa Director Jan 3, 2023
George Christopher Eliades Director Jan 3, 2023
Benjamin Tsai Director Jan 3, 2023
Mark Anthony Murray Director Jan 3, 2023
Daniel Lochner Chief Financial Officer Dec 1, 2022
Jeffrey Nau President and CEO, Director Dec 1, 2022
New Enterprise Associates 14, L.P. 10%+ Owner Jan 3, 2023
Michael G. Atieh Director Jan 3, 2023
InvOpps GP IV, L.L.C. Director, 10%+ Owner Jan 3, 2023
Ali Behbahani Director Jan 3, 2023
Aimee S. Weisner Director Jan 3, 2023

Recent Insider Transactions by Companies or Individuals for Oyster Point Pharma, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership